---
title: "10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292810883.md"
description: "10x Genomics (Nasdaq: TXG) announced it will report its second-quarter 2026 financial results for the period ended June 30, 2026, after market close on August 6, 2026. The company will host a public conference call and live webcast at 1:30 p.m. PT to discuss results and outlook. Financial results will be available on the company website prior to the call."
datetime: "2026-07-15T20:05:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292810883.md)
  - [en](https://longbridge.com/en/news/292810883.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292810883.md)
---

# 10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026

PLEASANTON, Calif., July 15, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, announced it will report financial results for the second quarter ended June 30, 2026 after market close on Thursday, August 6, 2026. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.

Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.

**About 10x Genomics**

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.

**Disclosure Information**

10x Genomics uses filings with the Securities and Exchange Commission, its website (https://www.10xgenomics.com/), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

**Contacts**

Investors: investors@10xgenomics.com

Media: media@10xgenomics.com

SOURCE 10x Genomics, Inc.

### Related Stocks

- [TXG.US](https://longbridge.com/en/quote/TXG.US.md)

## Related News & Research

- [Ørsted publishes update on Q2 2026 results release and earnings call](https://longbridge.com/en/news/295061539.md)
- [VGP to host webcast on H1 2026 results](https://longbridge.com/en/news/295056101.md)
- [Mobilezone schedules investor video conference on H1 2026 results](https://longbridge.com/en/news/294935560.md)
- [Azul updates financial events calendar for 2026](https://longbridge.com/en/news/295022865.md)
- [Allianca Saude updates financial events calendar for 2026](https://longbridge.com/en/news/295018178.md)